Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

19

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

178087380

Full Text :

https://doi.org/10.1200/JCO.23.01909